Jakub Hlávka, PhD's social media accounts
Jakub Hlávka, PhD's contact information
Jakub Hlávka, PhD's Bio
Jakub Hlávka, PhD, is a Research Assistant Professor in the Health Policy and Management Department of the Price School of Public Policy and Schaeffer Center for Health Policy & Economics, University of Southern California. His NIH-funded research focuses on the modeling of dementia treatments and associated economic challenges, with a specific focus on Alzheimer’s disease and emerging disease-modifying therapies. He has also worked on models of COVID-19 pandemic interventions estimating their costs and benefits. His broader research interests include innovative payment models for pharmaceuticals, health system reform and the study of inequality.
He currently serves as a research consultant for the National Academies of Sciences, Engineering, and Medicine (Committee on Improving Representation of Women and Underrepresented Minorities in Clinical Trials and Research), and is a member of the International Pharmacoeconomics Collaboration on Alzheimer’s Disease (IPECAD). Prof. Hlávka has additional professional experience from Genentech where he assisted in R&D portfolio planning and as a consultant to the Tufts Medical Center's Center for the Evaluation of Value and Risk in Health where he studied oncology-specific outcome measures.
Aside from healthcare, he has co-authored studies in national security, aerospace and emerging technologies and has served in research and consulting roles at the Fraunhofer Society (Germany), RAND Europe in Cambridge (England), and at the Office of the Government and Ministry of Finance in Prague (Czech Republic).
Dr. Hlávka holds a PhD from the Pardee RAND Graduate School, a master’s degree from Georgetown University, Edmund A. Walsh School of Foreign Service, and an undergraduate degree from the University of Economics in Prague.
Visit his personal website here.